Home Health Immune therapy may be an alternate therapeutic approach for treating chronic hepatitis B

Immune therapy may be an alternate therapeutic approach for treating chronic hepatitis B

3 min read

ISLAMABAD, Aug  26(ABC): Hepatitis B virus (HBV) infection is global in nature and induces several incredible liver diseases, such as chronic hepatitis B (CHB), cirrhosis of the liver (LC) and hepatocellular carcinoma (HCC). A total of 882,000 patients died of HBV-related liver diseases in 2019.

This large number of deaths and HBV morbidity can be contained if patients with CHB are provided with proper management strategies. Currently, two varieties of antiviral drugs are approved for the treatment of CHB patients. However, the outcome of treatment with these antiviral drugs is neither rationally satisfactory nor patient-friendly. These drugs come with major limitations, such as cost, infinite usage, adverse effects, and low efficacy.

On the basis of the retrieved information, it seems that immune therapy may be an alternate therapeutic approach for treating CHB patients. In this article, it is shown why antiviral drugs and innovative antiviral compounds have limited roles in the treatment of CHB patients. On the other hand, the scope of immune therapies has been rationalized by providing scientific evidence and analyzing the mechanism of action of CHB. Therefore, various immune therapy designs have been proposed for treating CHB patients.

Author

  • FD News

    Financial Daily (FD) is an emerging media outlet providing news reports, analysis and features especially related to politics and economy. FD is currently one of the largest and most comprehensive private-sector information portals in Pakistan, providing its readers with apolitical, unbiased and fact-based news reports and analyses.

Load More Related Articles
Load More By 
Load More In Health

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also

Commissioning of Central Control of New Gwadar Airport completed

GWADAR, Dec 20 (INP): The final testing and commissioning of the Central Control & Co…